Sun Pharma to raise Rs 10,000 crore to part-finance Organon deal
Sun Pharmaceutical pursued an acquisition in a mutual funds development.
· Economic Times Markets, ET Stocks
Sun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance bridge loans taken for the Organon acquisition valued at $11.75 billion. The first tranche will amount to ₹7,000 crore with a coupon rate of 8.20%.
The analysis
Sun Pharmaceutical reported Rs 10,000 crore and ₹7,000 crore, with movement of 8.20% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is +0.9% on the day at ₹1,777.70, and has returned -11.2% over three months. It sits 11% below its 52-week high. The pharma & healthcare sector has moved -0.9% over the same period, so Sun Pharmaceutical is running 10.3 points behind its peers.
For Sun Pharmaceutical, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.
Why it matters
- Fund flows and NAV moves show where domestic retail conviction is actually going, month after month.
Market context
- The 3 companies named span 2 sectors, so these are separate company stories rather than one sector-wide move.
- On the day, 2 of 3 are higher: Sun Pharmaceutical leads at +0.9% and State Bank of India (SBI) trails at -1.0%.
- Over three months: Sun Pharmaceutical -11.2% against Pharma & Healthcare -0.9% (10.3 points behind); State Bank of India (SBI) -6.2% against Banks -6.0% (0.2 points behind); ICICI Bank -2.5% against Banks -6.0% (3.5 points ahead).
- Trading well above normal today: Sun Pharmaceutical at 3.4 times its 20-day average volume.
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Sun PharmaceuticalSUNPHARMA · Pharma & Healthcare | ₹1,777.70 | +0.9% | -2.1% | -11.2% | -11.2% | 3.4× | — |
| State Bank of India (SBI)SBIN · Banks | ₹961.85 | -1.0% | +0.2% | -6.2% | -21.7% | 0.9× | — |
| ICICI BankICICIBANK · Banks | ₹1,398.00 | +0.8% | +5.8% | -2.5% | -4.4% | 0.9× | — |
Pharma & Healthcare
1M -0.6% · 3M -0.9%
Sun Pharmaceutical
Banks
1M -3.4% · 3M -6.0%
State Bank of India (SBI), ICICI Bank
Prices as of 30 Oct 2026, 16:11 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
SBI Mutual Fund's AUM rises 10% to ₹13.1 trn; H1 operating profit up 11%
Jio IPO: Which mutual funds bet big, and where did your SIP money go?
No. 2 on Day 1: How Jio Platforms broke India’s market cap hierarchy on debut itself
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings
Breakout stocks: Adani Ports, Nykaa, Saregama on radar; analyst tells why